Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2006

View Archived Issues

New anti-HIV fusion protein from FusoGen

Biologic responses observed in RA patients treated with TACI-Ig

VX-950 plus PEG-IFN reduces plasma viral RNA in chronic genotype 1 HCV patients

Protein Design Labs changes name to PDL BioPharma

Lilly to develop Kyowa Hakko's mitotic kinesin Eg5 inhibitor

KAI Pharmaceuticals and Sankyo sign agreement for KAI-9803

Applied Biosystems transfers interest in Celera Diagnostics to Celera Genomics

Novartis will not make offer to acquire Berna Biotech

HIV integrase inhibitor GS-9137 completes phase I/II study

Data support bioequivalence of new Sustiva/Truvada fixed-dose formulation

Enrollment open in dose-ranging study of TBC-3711 in resistant hypertension

New approval for Emend

FMPD: Lilly's new candidate for psychosis

Alkermes and Lilly sign agreement for inhaled PTH development

AVN-944 begins phase I study in advanced hematological malignancies

Novel SARMs subject of Merck & Co. patent

NIAID grant supports influenza A vaccine development at Juvaris

Novel agents for treating neurological disorders disclosed in recent sanofi-aventis patent

Evotec licenses two MAO-B inhibitors from Roche for Alzheimer's disease

Phase I study evaluates IPI-504 in patients with GIST

European orphan drug status for denufosol tetrasodium in cystic fibrosis

Tranzyme cleared to begin phase I study of TZP-101

Tesmilifene studied with docetaxel in rapidly progressing metastatic breast cancer

Replidyne submits Orapem NDA

Menarini's promising new low-dose candidate for bronchoconstriction

Oxazolidinones with Gram-negative activity synthesized

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...